title: Loss of FHIT expression in transitional cell carcinoma of the urinary bladder.
abstract: Cytogenetic and loss of heterozygosity (LOH) studies demonstrated chromosome 3p deletions in transitional cell carcinoma (TCC). We recently cloned the tumor suppressor gene FHIT (fragile histidine triad) at 3p14.2, one of the most frequently deleted chromosomal regions in TCC of the bladder, and showed that it is the target of environmental carcinogens. Abnormalities at the FHIT locus have been found in tumors of the lung, breast, cervix, head and neck, stomach, pancreas, and clear cell carcinoma of the kidney. We examined six TCC derived cell lines (SW780, T24, Hs228T, CRL7930, CRL7833, and HTB9) and 30 primary TCC of the bladder for the integrity of the FHIT transcript, using reverse transcriptase-polymerase chain reaction (RT-PCR) to investigate a potential role of the FHIT gene in TCC of the bladder. In addition, we tested expression of the Fhit protein in the six TCC-derived cell lines by Western blot analysis and in 85 specimens of primary TCCs by immunohistochemistry. Three of the six cell lines (50%) did not show the wild-type FHIT transcript, and Fhit protein was not detected in four of the six cell lines (67%) tested. Fhit expression also was correlated with pathological and clinical status. A significant correlation was observed between reduced Fhit expression and advanced stage of the tumors. Overall, 26 of 30 (87%) primary TCCs showed abnormal transcripts. Fhit protein was absent or greatly reduced in 61% of the TCCs analyzed by immunohistochemistry. These results suggested that loss of Fhit expression may be as important in the development of bladder cancer as it is for other neoplasms caused by environmental carcinogens.
authors.affiliation: Department of Urology, Kimmel Cancer Center, Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania, USA. R_Baffa@lac.jci.tju.edu
authors.forename: R
authors.initials: R
authors.lastname: Baffa
authors.forename: L G
authors.initials: LG
authors.lastname: Gomella
authors.forename: A
authors.initials: A
authors.lastname: Vecchione
authors.forename: P
authors.initials: P
authors.lastname: Bassi
authors.forename: K
authors.initials: K
authors.lastname: Mimori
authors.forename: J
authors.initials: J
authors.lastname: Sedor
authors.forename: C M
authors.initials: CM
authors.lastname: Calviello
authors.forename: M
authors.initials: M
authors.lastname: Gardiman
authors.forename: C
authors.initials: C
authors.lastname: Minimo
authors.forename: S E
authors.initials: SE
authors.lastname: Strup
authors.forename: P A
authors.initials: PA
authors.lastname: McCue
authors.forename: A J
authors.initials: AJ
authors.lastname: Kovatich
authors.forename: F
authors.initials: F
authors.lastname: Pagano
authors.forename: K
authors.initials: K
authors.lastname: Huebner
authors.forename: C M
authors.initials: CM
authors.lastname: Croce
mesh_terms: D017766:Acid Anhydride Hydrolases; D015153:Blotting, Western; D002295:Carcinoma, Transitional Cell / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D005260:Female; D017353:Gene Deletion; D006720:Homozygote; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D009363:Neoplasm Proteins; D009367:Neoplasm Staging; D011506:Proteins / Q000235:genetics / Q000378:metabolism*; D012333:RNA, Messenger / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014407:Tumor Cells, Cultured; D001749:Urinary Bladder Neoplasms / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D000099170:Bis(5'-adenosyl)triphosphatase
chemical_list: D017766:Acid Anhydride Hydrolases; D009363:Neoplasm Proteins; D011506:Proteins; D012333:RNA, Messenger; D000099170:Bis(5'-adenosyl)triphosphatase